Lyka Labs has received an approval for sale of manufacturing facilities of formulations located at Tarapur in state of Maharashtra
Lyka Labs is currently trading at Rs. 15.40, up by 0.35 points or 2.33 % from its previous closing of Rs. 15.05 on the BSE.
The scrip opened at Rs. 15.10 and has touched a high and low of Rs. 15.65 and Rs. 15.10 respectively. So far 4731 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 21.70 on 13-Jun-2014 and a 52 week low of Rs. 8.46 on 07-Aug-2013.
Last one week high and low of the scrip stood at Rs. 18.40 and Rs. 15.00 respectively. The current market cap of the company is Rs. 33.23 crore.
The promoters holding in the company stood at 23.30 % while Institutions and Non-Institutions held 4.93 % and 71.78 % respectively.
Lyka Labs has received an approval for sale of manufacturing facilities of formulations located at Tarapur in state of Maharashtra. The board of directors at its meeting held on July 14, 2014 has approved for the same. The board also approved to seek approval of shareholders through Postal Ballot for sale of manufacturing facilities.
Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1660.45 |
| Dr. Reddys Lab | 1215.40 |
| Cipla | 1226.30 |
| Zydus Lifesciences | 928.40 |
| Lupin | 2300.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: